[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-344933-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-344933-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","factors-associated-with-occurrence-of-drug-therapy-problems-among-patients-with-neoplasms-of-digestive-organs-at-uganda-cancer-institute-mbarara-a-cross-sectional-study","Factors associated with occurrence of drug therapy problems among patients with neoplasms of digestive organs at Uganda Cancer Institute, Mbarara - a cross-sectional study","","Neoplasms of digestive organs represent a rising global burden, and although stakeholders work to improve access to relatively safe chemotherapy, cancer drug therapy problems (DTPs) can undermine treatment outcomes. Limited data exist in Uganda regarding the burden of DTPs among patients receiving cancer chemotherapy. This cross-sectional study evaluated DTP prevalence and associated factors among 196 participants at Uganda Cancer Institute, Mbarara.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/factors-associated-with-occurrence-of-drug-therapy-problems-among-patients-with-neoplasms-of-digestive-organs-at-uganda-cancer-institute-mbarara-a-cross-sectional-study/344933/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/factors-associated-with-occurrence-of-drug-therapy-problems-among-patients-with-neoplasms-of-digestive-organs-at-uganda-cancer-institute-mbarara-a-cross-sectional-study/344933.png","ImageObject",300,407,{"name":42,"@type":43},"Emma Wilson","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-14","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What were the objectives of the cross-sectional study?","Question",{"text":63,"@type":64},"To determine the prevalence of drug therapy problems and identify factors associated with their occurrence among patients receiving cancer chemotherapy for neoplasms of digestive organs at Uganda Cancer Institute, Mbarara.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How many participants experienced drug therapy problems, and which types were most common?",{"text":68,"@type":64},"Out of 196 participants, 86 (43.9%) experienced DTPs. The most common DTPs were the need for additional therapy (25.2%), unnecessary drug therapy (16.1%), and adverse drug reactions (16.1%).",{"name":70,"@type":61,"acceptedAnswer":71},"Which factors were significantly associated with drug therapy problems?",{"text":72,"@type":64},"Female gender (aOR 2.11; p=0.047), unemployment (aOR 7.17; p=0.023), and older age (aOR 2.67; p=0.007) were significantly associated with DTP occurrence.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},344933,1790170808,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":116,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},3848291630094,"https://eur-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Ojuka etal. BMC Cancer (2026) 26:348 BMC Cancer  \n[https://doi.org/10.1186/s12885-026-15657-4](https://doi.org/10.1186/s12885-026-15657-4)  \nRESEARCH Open Access  \nFactors associated with occurrence  \nof drug therapy problems among patients with neoplasms of digestive organs at Uganda Cancer Institute, Mbarara: a cross-sectional study  \nSilas Ojuka1†, Alex Duhimbaze2†, Samuel Michael Nono2, Moses Nangosya2, John Isiiko3 and Tadele Mekuriya Yadesa2,4*  \nAbstract  \nBackground The global burden of neoplasms of digestive organs (NDOs) is on the rise. Various stakeholders have made significant efforts to ensure access to effective and relatively safe chemotherapy for the treatment of NDOs. However, the use of cancer chemotherapy has been associated with drug therapy problems (DTPs) . These potentially compromise desired treatment outcomes. There is limited knowledge among stakeholders regarding the burden of DTPs among patients on cancer chemotherapy in Uganda.  \nMethod This was a cross-sectional study which enrolled 196 participants with NDOs. It was conducted at Uganda Cancer Institute (UCI), Mbarara. Data was collected using a questionnaire and checklist. Data analysis was performed using Statistical Package for Social Sciences (SPSS) version 22.0. The prevalence of DTPs was expressed as a percentage of the sample size. Factors associated with occurrence of DTPs were analyzed using logistic regression. Variables with p-values less than 0.25 at univariate analysis were subjected to multivariate analysis. Variables were considered statistically significant if p-values were less than 0.05 at 95% confidence interval.  \nResults Out of 196 participants 86 (43 . 9%) experienced DTPs. The most common DTPs were: need for additional therapy (135/535, 25 . 2%), unnecessary drug therapy (86/535, 16. 1%) and adverse drug reactions (ADRs) (86/535, 16. 1%) . On performing logistic regression, female gender (aOR: 2 . 11; 95% CI: 1.01–4.42, p = 0 . 047), unemployment (aOR: 7. 17; 95% CI: 1.31–39. 02, p = 0 . 023) or older age (aOR: 2 . 67; 95% CI: 1.31–5.47, p = 0 . 007) were significantly associated with occurrence of DTPs.  \n†Silas Ojuka and Alex Duhimbaze contributed equally to this work.  \n*Correspondence: Tadele MekuriyaYadesa [maatiikoo4@gmail.com](maatiikoo4@gmail.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026, modified publication 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercialNoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://cre](http://cre)[ativecommons.org/licenses/by-nc-nd/4.0/](ativecommons.org/licenses/by-nc-nd/4.0/.)[.](ativecommons.org/licenses/by-nc-nd/4.0/.)  \nOjuka et al. BMC Cancer (2026) 26:348 Page 2 of 9  \nConclusion This study demonstrates that the use of cancer chemotherapy to achieve desired therapy outcomes among patients with NDOs is still challenged by DTPs. The findings are suggestive of a gap in rational medicines use in the treatment of cancers in a LMIC setting.  \nKeywords Drug therapy problem, Neoplasm of digestive organ, Cancer, Chemotherapy  \nBackground  \nGlobally 4.8 million new cases ","cbCaicUZd6cWJEhs","https://ap.wps.com/l/cbCaicUZd6cWJEhs","pdf",1392017,"English","# Abstract\n## Background\n## Method\n## Results\n## Conclusion\n# Keywords\n# Background","[{\"question\":\"What were the objectives of the cross-sectional study?\",\"answer\":\"To determine the prevalence of drug therapy problems and identify factors associated with their occurrence among patients receiving cancer chemotherapy for neoplasms of digestive organs at Uganda Cancer Institute, Mbarara.\"},{\"question\":\"How many participants experienced drug therapy problems, and which types were most common?\",\"answer\":\"Out of 196 participants, 86 (43.9%) experienced DTPs. The most common DTPs were the need for additional therapy (25.2%), unnecessary drug therapy (16.1%), and adverse drug reactions (16.1%).\"},{\"question\":\"Which factors were significantly associated with drug therapy problems?\",\"answer\":\"Female gender (aOR 2.11; p=0.047), unemployment (aOR 7.17; p=0.023), and older age (aOR 2.67; p=0.007) were significantly associated with DTP occurrence.\"}]","Factors associated with occurrence of drug therapy problems among patients with neoplasms of digestive organs at Uganda Cancer Institute, Mbarara - a cross-sectional study | PDF",1790055827,23,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b1c84489cdd909f87a1cdb7deca2acdd.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c618cd913492902d69e026bd7e825005.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c2809f98bc81aec8913e10c0f1844e9d.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/96445f1493514ac60d426fbba8bd16ab.webp",980,1306]